Compare SNPS & MCK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SNPS | MCK |
|---|---|---|
| Founded | 1986 | 1833 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | EDP Services | Other Pharmaceuticals |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 91.0B | 101.9B |
| IPO Year | 1992 | N/A |
| Metric | SNPS | MCK |
|---|---|---|
| Price | $526.15 | $819.41 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 15 | 13 |
| Target Price | $566.13 | ★ $882.69 |
| AVG Volume (30 Days) | ★ 2.0M | 617.5K |
| Earning Date | 02-25-2026 | 02-04-2026 |
| Dividend Yield | N/A | ★ 0.40% |
| EPS Growth | N/A | ★ 66.19 |
| EPS | 8.05 | ★ 32.12 |
| Revenue | $7,054,178,000.00 | ★ $387,094,000,000.00 |
| Revenue This Year | $39.24 | $14.87 |
| Revenue Next Year | $10.82 | $8.33 |
| P/E Ratio | $63.94 | ★ $25.36 |
| Revenue Growth | 15.12 | ★ 17.23 |
| 52 Week Low | $365.74 | $570.51 |
| 52 Week High | $651.73 | $895.58 |
| Indicator | SNPS | MCK |
|---|---|---|
| Relative Strength Index (RSI) | 73.32 | 46.18 |
| Support Level | $469.07 | $806.10 |
| Resistance Level | $524.98 | $844.69 |
| Average True Range (ATR) | 12.45 | 14.12 |
| MACD | 4.14 | -0.16 |
| Stochastic Oscillator | 94.81 | 45.07 |
Synopsys is a provider of electronic design automation software and intellectual property products. EDA software automates and aids in the chip design process, enhancing design accuracy, productivity, and complexity in a full-flow end-to-end solution. Synopsys' comprehensive portfolio is benefiting from a convergence of semiconductor companies moving up the stack of technologies toward systems-like companies, and systems companies moving down-stack toward in-house chip design. The resulting expansion in EDA customers alongside secular digitalization of various end markets benefits EDA vendors like Synopsys.
McKesson Corp is one of three leading pharmaceutical wholesalers in the US engaged in sourcing and distributing branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospitals networks, and healthcare providers. Along with Cencora and Cardinal Health, the three account for over 90% of the US pharmaceutical wholesale industry. Outside the US market, McKesson engages in pharmaceutical wholesale and distribution in Canada. Additionally, the company supplies medical-surgical products and equipment to healthcare facilities and provides a variety of technology solutions for pharmacies.